Cargando…

Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma

Pancreatic cancer is the fourth leading cause of death from cancer in both men and women. Pancreatic cancer is typically diagnosed at an advanced stage and has an overall 5-year survival of approximately 9.3%. The National Comprehensive Cancer Network recommends both germline testing (testing cells...

Descripción completa

Detalles Bibliográficos
Autor principal: Grzelak, Doreen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299794/
https://www.ncbi.nlm.nih.gov/pubmed/34430059
http://dx.doi.org/10.6004/jadpro.2021.12.5.4